Conversely, MC4R antagonism or genetic disruption of MC4R causes hyperphagia, increased adiposity, insulin resistance and dyslipidemia without affecting BP, a finding that further confirms that insulin resistance and hyperinsulinemia are not the main drivers of obesity-induced hypertension [95–97]. The gene discussed is MC4R; the disease is metabolic syndrome.